Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print March 15, 2007
DOI: 10.2337/db06-1733

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1733v1
56/6/1630    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glund, S.
Right arrow Articles by Krook, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glund, S.
Right arrow Articles by Krook, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

IL-6 directly increases glucose metabolism in resting human skeletal muscle

Stephan Glund1, Atul Deshmukh1, Yun Chau Long1, Theodore Moller1, Heikki A Koistinen4, Kenneth Caidahl3, Juleen R Zierath1, and Anna Krook1,2

1Department of Molecular Medicine and Surgery, Section for Integrative Physiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
2Department of Physiology and Pharmacology, Section for Integrative Physiology, Karolinska Institutet, Stockholm, Sweden
3Department of Molecular Medicine and Surgery, Section for Clinical Physiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
4Helsinki University Central Hospital and Biomedicum, Helsinki, Finland

Correspondence: anna.krook{at}ki.se

Objective:: IL-6 is a pro-inflammatory cytokine shown to modify insulin sensitivity. Elevated plasma levels of IL-6 are observed in insulin resistant states. Interestingly, plasma IL-6 levels also increase during exercise, with skeletal muscle being the predominant source. Thus, IL-6 has also been suggested to promote insulin-mediated glucose utilization. We determined the direct effects of IL-6 on glucose transport and signal transduction in human skeletal muscle.

Research Design and Methods:: Skeletal muscle strips were prepared from vastus lateralis biopsies obtained from 22 healthy men. Muscle strips were incubated with or without IL-6 (120 ng/ml).

Results:: IL-6 increased glucose transport in human skeletal muscle 1.3 fold (P<0.05). A 30 min pre-exposure to IL-6 did not affect insulin-stimulated glucose transport. IL-6 also increased skeletal muscle glucose incorporation into glycogen, and glucose oxidation (1.5 fold and 1.3 fold, respectively, P<0.05). IL-6 increased phosphorylation of STAT3 (P<0.05), AMPK (P=0.063), and p38 MAPK (P<0.05), and reduced phosphorylation of S6 ribosomal protein (P<0.05). In contrast, phosphorylation of PKB/Akt, AS160, GSK3{alpha}/ß, as well as IRS1-associated PI 3-kinase activity was unaltered.

Conclusion:: Acute IL-6 exposure increases glucose metabolism in resting human skeletal muscle. Insulin-stimulated glucose transport and insulin signaling were unchanged following IL-6 exposure.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.